Cargando…
Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab
Developing therapeutic monoclonal antibodies paves the way for new strategies in oncology using targeted therapy which should improve specificity. However, due to a lack of biomarkers, a personalized therapy scheme cannot always be applied with monoclonal antibodies. As a consequence, the efficacy o...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741214/ https://www.ncbi.nlm.nih.gov/pubmed/23951280 http://dx.doi.org/10.1371/journal.pone.0072021 |